The European Union has recently made known the addition of Israel to the list of countries with an appropriate regulatory system for supervising active pharmaceutical ingredients for the manufacture of medicinal products. The implication of this is recognition of supervision by the Institute for Standardization and Control of Pharmaceuticals/Pharmaceutical Administration in the Ministry of Health of good manufacturing practices for active pharmaceutical ingredients. The recognition comes into force on 22-Jul-15.   From this date, Israeli manufacturers of active pharmaceutical ingredients who export to Europe will no longer need to present individual written confirmation from the authority in Israel for each export batch.